Characterization Data for Compounds 3a-f, 3h-r and 3t s-3 1 H NMR and 13 C NMR spectra of compounds 3a-f, 3h-r and 3t s-9
s-3
EXPERIMENTAL SECTION

General Information and Materials
The microwave heating was performed in a Biotage Initiator single mode reactor, which produces controlled irradiation at 2450 MHz. The reaction temperature was determined using the built-in online IR sensor. Microwave mediated reactions were performed in sealed Smith process vials designed for 2-5 mL reaction volumes. NMR spectra were recorded on a Varian Mercury plus at 25 °C and 400 MHz for 1 H and 101 MHz for 13 C. Chemical shifts (δ) are reported in ppm and referenced indirectly to TMS via the solvent (or residual solvent) signals. GC-MS analyses were done with a CP-SIL 8 CB Low Bleed/MS (30 m × 0.25 mm, 0.25 µm) capillary column using a 70-300 °C temperature gradient and EI ionization (70 eV). Analytical RPLC-MS was performed in a gradient mode on a system equipped with a Chromolith Speed ROOD RP-18e 50 x 4.6 mm column using H2O/MeOH (0.05% HCOOH) as mobile phase at a flow rate of 4 mL/min with UV (214 and 254 nm) and MS (ESI) detection. Molecular masses (HR-ESI-MS) were determined on a mass spectrometer equipped with an electrospray ion source. All starting materials, reagents and solvents are commercially available and were used as received. Arylamidine products 3b, 3c, 3e, 3f, 3h-j, 3l, 3m, 3p, 3r and 3t are to the best of our knowledge new compounds. Products 3a, 3d, 3k, 3n, 3o and 3q are commercially available.
General Procedure for the Synthesis of Arylamidines
To a 2-5 mL process vial Pd(O 2 CCF 3 ) 2 (13.3 mg, 0.04 mmol), 6-methyl-bipyridyl (10.2 mg, 0.06 mmol) and MeOH (3.0 mL) were added and the mixture was stirred for 5 min before addition of cyanamide, 2, (1 mmol), trifluoroborate, 1, (1.1 mmol) and trifluoroacetic acid (228 mg, 2 mmol) was added to the reaction mixture and the vial was instantly capped under air and then heated using microwave irradiation at 120 °C for 20 min. The reaction mixture was then diluted with 20 mL NaHCO 3 aq. and washed with 20 mL DCM. The organic phase was further extracted with 2 x 20 mL NaHCO 3 aq. The combined aqueous phases were basified to pH ~ 14 by the addition of NaOH and extracted with 3 x 60 mL DCM. The combined organic phases were dried and concentrated to provide the pure isolated product in the yield stated in Tables 1, 2 9, 160.2, 131.3, 128.4, 113.9, 55.4, 47.4, 25.9, 24.9 . HRMS calc. 219.1497 found 219.1500.
3c
The title compound was prepared according to the general procedure to yield the arylamidine 3c (181 mg, 74% yield) as a colorless liquid. 
3d
The title compound was prepared according to the general procedure to yield the arylamidine 3d (138 mg, 73% yield) as a colorless liquid.
1 H NMR (400 MHz, CDCl 3 ) δ = 7.38-7.31 (m, 5H), 3.33 (m, 4H), 1.67-1.52 (m, 6H).
13 C NMR (101 MHz, CDCl 3 ) δ = 169. 9, 139.0, 129.0, 128.6, 126.9, 47.2, 25.9, 24.8. HRMS calc. 189 .1392 found 189.1394.
3e
The title compound was prepared according to the general procedure to yield the arylamidine 3e (168 mg, 63% yield) as a colorless liquid.
1 H NMR (400 MHz, CDCl 3 ) δ = 7.50 (m, 2H), 7.21 (m, 2H), 3.31 (m, 4H), 1.63 (m, 2H), 1.58 (m, 4H).
13 C NMR (101 MHz, CDCl 3 ) δ = 168. 7, 137.9, 131.9, 128.6, 123.2, 47.4, 25.9, 24.8. HRMS calc. 267 .0497 found 267.0496.
s-5 3f
The title compound was prepared according to the general procedure to yield the arylamidine 3f (86 mg, 37% yield) as a colorless liquid. 
3i
The title compound was prepared according to the general procedure to yield the arylamidine 3i (96 mg, 40% yield) as a colorless liquid.
1 H NMR (400 MHz, CDCl 3 ) δ = 7.87-7.81 (m, 4H), 7.54-7.48 (m, 2H), 7.43 (m, 1H), 3.37 (m, 4H), 1.68-1.56 (m, 6 H).
13 C NMR (101 MHz, CDCl 3 ) δ = 169. 9, 136.5, 133.5, 133.1, 128.3, 128.3, 127.8, 126.8, 126.7, 126.2, 124.6, 47.1, 25.9, 24.8. HRMS calc. 239 .1548 found 239.1555.
3j
The title compound was prepared according to the general procedure to yield the arylamidine 3j (118 mg, 66% yield) as a colorless liquid.
1 H NMR (400 MHz, CDCl 3 ) δ = 7.42 (dd, J = 0.8, 1.8 Hz, 1H), 6.55 (dd, J = 0.8, 3.3 Hz, 1 H), 6.41 (dd, J = 1.8, 3.3 Hz, 1H), 3.37 (m, 4H), 1.68-1.55 (m, 6H).
13 C NMR (101 MHz, CDCl 3 ) δ = 160. 0, 149.2, 143.0, 111.0, 111.0, 47.7, 25.9, 24.9 167.7, 138.7, 136.7, 128.9, 125.9, 48.4, 19.9, 19.4 . HRMS calc. 219.1861 found 219.1864.
3q
The title compound was prepared according to the general procedure to yield the arylamidine 3q (122 mg, 64% yield) as a colorless liquid.
1 H NMR (400 MHz, CDCl 3 ) δ = 7.38 (m, 2H), 7.17 (m, 2H), 2.36 (s, 3H), 1.47 (s, 9H).
13 C NMR (101 MHz, CDCl 3 ) δ = 164. 4, 139.8, 137.6, 129.3, 125.9, 51.4, 29.0, 21.4. HRMS calc. 191.1548 4, 139.8, 137.6, 129.3, 125.9, 51.4, 29.0, 21.4. HRMS calc. 191. found 191.1546 .
3r
The title compound was prepared according to the general procedure to yield the arylamidine 3r (119 mg, 58% yield) as a colorless liquid.
1 H NMR (400 MHz, CDCl 3 ) δ = 7.24 (m, 2H), 7.18 (m, 2H), 3.71 (m, 4H), 3.35 (m, 4H), 2.36 (s, 3H).
13 C NMR (101 MHz, CDCl 3 ) δ = 170. 2, 139.6, 134.9, 129.4, 127.1, 66.9, 46.8, 21.4 
